back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 13:55 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
173,180 | |
| Filed 2024-02-08 13:55 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-125,000 vol |
0 | |
| Filed 2024-02-04 10:53 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2024-01-04 15:46 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+26,668 vol |
48,180 | |
| Filed 2024-01-04 15:45 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-26,668 vol |
0 | |
| Filed 2023-03-19 20:32 Tx date 2023-03-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-13,332 vol |
26,668 | |
| Filed 2023-03-19 20:31 Tx date 2023-03-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+13,332 vol |
21,512 | |
| Filed 2023-03-14 13:01 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+30,000 vol |
40,000 | |
| Filed 2023-03-14 13:00 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+30,000 vol |
40,000 | |
| Filed 2023-03-14 12:58 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+6,135 vol |
8,180 | |
| Filed 2022-09-05 19:02 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2022-09-05 19:01 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
10,000 | |
| Filed 2022-04-08 16:10 Tx date 2022-02-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 16:09 Tx date 2022-02-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 16:09 Tx date 2022-02-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 16:09 Tx date 2022-04-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,822
+2,045 vol $6.27 each |
2,045 | |
| Filed 2022-04-08 16:08 Tx date 2022-02-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Gutman, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|